Risk-Reducing Salpingo-Oophorectomy

Risk-reducing salpingo-oophorectomy removes both fallopian tubes and ovaries to lower the risk of related cancers in selected high-risk patients.

Risk-reducing salpingo-oophorectomy removes the fallopian tubes and ovaries before cancer is diagnosed. It is considered for some people with a high inherited risk, including some carriers of a BRCA gene mutation. Removing the ovaries causes loss of ovarian hormone production and brings on menopause if it has not already occurred. The operation is preventive, not a treatment for an unexplained pelvic symptom.

A gynaecologic surgeon reviews genetic results, family history, reproductive plans, menstrual status, medicines, and other health conditions. The procedure is often performed using keyhole surgery under general anaesthesia, although an open approach may be appropriate. Both tubes and ovaries are removed, and the tissue is examined by a laboratory. The timing is individualised because prevention benefits must be weighed against fertility and menopause concerns.

Common short-term effects include abdominal discomfort, bloating, tiredness, shoulder-tip pain after keyhole surgery, and temporary bowel changes. Early menopause may cause hot flushes, sleep disturbance, vaginal dryness, mood changes, and reduced sexual comfort. Serious complications can include bleeding, infection, injury to the bowel, bladder, ureter, or blood vessels, anaesthetic problems, and blood clots. Seek urgent care for severe pain, heavy bleeding, fever, fainting, chest pain, or breathlessness.

For people selected because inherited risk is high, removing the tubes and ovaries lowers the risk of ovarian, fallopian-tube, and related peritoneal cancers. It cannot remove every possible cancer risk. The long-term outcome also depends on managing early menopause, sexual health, bone health, and emotional wellbeing. Your genetics and gynaecology teams can explain how timing affects your personal goals.

The operation ends the ability to release eggs and usually ends natural fertility. It may reduce ovarian hormone production abruptly. Hormone therapy may be discussed for selected people, depending on personal cancer history and other factors. Follow-up should include a plan for symptoms and health needs after surgery.

Specialists may discuss it with people whose genetic result and family history indicate elevated risk of ovarian or related cancers. A BRCA gene mutation is one example. Timing may depend on age, childbearing plans, prior cancer treatment, and whether the ovaries are still functioning. Genetic counselling is useful before making an irreversible decision.

Before surgery, the team confirms the genetic and surgical plan, checks medicines, and discusses fertility and menopause care. During the operation, the surgeon removes both tubes and ovaries and inspects the pelvis. Tissue is sent for detailed examination. Recovery-room staff then monitor pain, nausea, urination, bleeding, and movement before discharge planning.

Walking is encouraged as soon as the clinical team advises, while strenuous activity and heavy lifting wait until healing is established. Keyhole incisions may feel sore and tight for several days. Energy often returns gradually, and menopause symptoms may appear or change after discharge. Attend the postoperative review and report wound changes, persistent pain, urinary problems, or bowel symptoms.

Risks depend on the surgical approach and your health. They include bleeding, infection, wound problems, injury to nearby organs, blood clots, anaesthetic reactions, and persistent pelvic discomfort. The abrupt hormone change can affect sleep, mood, sexual comfort, and bone health. Discuss smoking, clot history, medicines, and any previous pelvic surgery before the procedure.

Depending on your inherited risk, alternatives may include specialist surveillance, a different timing plan, or discussing removal of the tubes with later ovarian management in carefully selected circumstances. These approaches do not have the same effects on hormone production or risk. Menopause Management After Cancer explains symptom-care topics that may also be relevant after risk-reducing surgery.

Choose a gynaecologic surgeon familiar with inherited cancer risk and access to genetics, pathology, menopause, and fertility support. Ask how the operation will be performed, how tissue is examined, what symptoms require urgent help, and who will guide hormone, bone, sexual, and emotional health afterward.